Gerresheimer (ETR:GXI) target upped to 70.00EUR, issued a report today by Kepler Cheuvreux
- Updated: October 6, 2016
In a report issued 10/6/2016 Kepler Cheuvreux upped the price target of Gerresheimer (ETR:GXI) to 70.00EUR reporting a potential downside of -0.06%.
Previously on Wednesday October 05, 2016, Hauck & Aufhäuser Privatbankiers KGaA released a statement for Gerresheimer (ETR:GXI) raised the target price from 0.00EUR to 80.00EUR that indicated a possible upside of 0.05%.
Yesterday Gerresheimer (ETR:GXI) traded 0.00% even at 74.35EUR. The company’s 50-day moving average is 0.00EUR and its two hundred day average is 0.00EUR. With the last close up 0.00% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time. 0 shares of Gerresheimer exchanged hands, down from an average trading volume of 0
Recent Performance Chart
With a total market value of 0 EUR, Gerresheimer has with a one year low of 0.00EUR and a one year high of 0.00EUR .
More About Gerresheimer (ETR:GXI)
Gerresheimer AG is a Germany-based company that operates in the pharmaceuticals and health care industry. It is structured in three business segments: Plastic and Devices, Primary Packaging Glass and Life Science Research. The Company produces pharmaceutical packaging products, as well as drug-delivery systems made out of glass and plastics or a combination of both. Its product portfolio includes insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.